Research programme: immunotherapeutic cancer vaccines - Invectys
Alternative Names: INMAB-1Latest Information Update: 28 Apr 2020
At a glance
- Originator Invectys
- Class Cancer vaccines; DNA vaccines; Monoclonal antibodies; Subunit vaccines
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Apr 2020 No recent reports of development identified for preclinical development in Cancer in France (Parenteral)
- 10 Mar 2016 Preclinical trials in Cancer in France (Parenteral)
- 03 Dec 2014 Early research in Cancer in France (Parenteral)